Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
AiCuris
AiCuris is a clinical-stage biopharmaceutical company focused on resistance breaking antiviral and antibacterial therapeutics targeting Human Cytomegalovirus, Herpes simplex, HIV, Hepatitis B and C…
AiCuris
AiCuris is a clinical-stage biopharmaceutical company focused on resistance breaking antiviral and antibacterial therapeutics targeting Human Cytomegalovirus, Herpes simplex, HIV, Hepatitis B and C…
TL;DR
Stage: Clinical-stage biopharma
Headquarters: Wuppertal, Germany
Founded: 2006
Focus: Resistance-breaking antiviral and antibacterial therapeutics
Notable program: pritelivir (late-stage candidate for HSV)
Company Overview
Problem Domain
Antiviral and antibacterial infections, especially in immunocompromised patients; drug resistance.
Founded
2006
Industry
Biopharmaceuticals / Anti-infectives
Funding Track Record
74800000.00
920000000.00
Reported acquisition of AiCuris for $920M
Investor Signal
“Struengmann family office listed as a primary strategic investor; Helmut Jeggle (Salvia GmbH) represented on supervisory board”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week